Among the buyers were Abu Dhabi Investment Authority, BNP Paribas Financial Markets, Copthall Mauritius Investment Limited, Ghisallo Master Fund LP, Goldman Sachs (Singapore) Pte, Societe Generale, Morgan Stanley Asia Singapore Pte and a clutch of funds from the stable of US asset management firm T. Rowe Price.
Between them they bought Apollo Hospitals shares worth Rs 952 crore. Eight funds of T. Rowe Price together bought shares worth Rs 327.36 crore. Societe Generale was the next top buyer at Rs 258 crore while US-based Ghisallo shopped for shares worth Rs 180 crore. Morgan Stanley affiliate bought shares worth Rs 134 crore.
BNP Paribas purchased equity worth Rs 22 crore while Abu Dhabi Investment, Copthall and Goldman Sachs each bought shares amounting to Rs 10 crore.
Among domestic entities, Kotak Mahindra Life Insurance Company, Bank of India Mutual Fund, Axis Mutual Fund and Tata Mutual Fund were buyers.
The shares were purchased at a price of Rs 7,850 a piece which was at a 1% discount over the Thursday closing price of Rs 7,926.50. The shares of Apollo Hospitals today closed flat at Rs 7,930.Apollo Hospitals Enterprise reported a consolidated net profit of Rs 433 crore in Q1, up 42% compared to Rs 305 crore reported in the year ago period. The profit after tax (PAT) was attributable to the owners of the company. Company’s revenue from operations in the quarter grew 15% to Rs 5,842 crore versus Rs 5,086 crore in Q1FY25.The PAT was 11% higher on a sequential basis versus Rs 390 crore in Q4FY25 while the topline increased 4.5% over Rs 5,592 reported by the company in Q4FY25.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
